Modeling Disease In Vivo With CRISPR/Cas9

被引:91
作者
Dow, Lukas E. [1 ]
机构
[1] Weill Cornell Med Coll, Dept Med Hematol & Med Oncol, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
ONE-STEP GENERATION; CAENORHABDITIS-ELEGANS GENOME; HOMOLOGY-DIRECTED REPAIR; OFF-TARGET MUTATIONS; STRAND-BREAK REPAIR; CRISPR-CAS9; SYSTEM; MUSCULAR-DYSTROPHY; HUMAN-CELLS; CHROMOSOMAL REARRANGEMENTS; EDITING SPECIFICITY;
D O I
10.1016/j.molmed.2015.07.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recent advent of CRISPR/Cas9-mediated genome editing has created a wave of excitement across the scientific research community, carrying the promise of simple and effective genomic manipulation of nearly any cell type. CRISPR has quickly become the preferred tool for genetic manipulation, and shows incredible promise as a platform for studying gene function in vivo. I discuss the current application of CRISPR technology to create new in vivo disease models, with a particular focus on how these tools, derived from an adaptive bacterial immune system, are helping us to better model the complexity of human cancer.
引用
收藏
页码:609 / 621
页数:13
相关论文
共 113 条
  • [91] GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
    Tsai, Shengdar Q.
    Zheng, Zongli
    Nguyen, Nhu T.
    Liebers, Matthew
    Topkar, Ved V.
    Thapar, Vishal
    Wyvekens, Nicolas
    Khayter, Cyd
    Iafrate, A. John
    Le, Long P.
    Aryee, Martin J.
    Joung, J. Keith
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (02) : 187 - 197
  • [92] Heritable Custom Genomic Modifications in Caenorhabditis elegans via a CRISPR-Cas9 System
    Tzur, Yonatan B.
    Friedland, Ari E.
    Nadarajan, Saravanapriah
    Church, George M.
    Calarco, John A.
    Colaiacovo, Monica P.
    [J]. GENETICS, 2013, 195 (03) : 1181 - +
  • [93] Genome editing with engineered zinc finger nucleases
    Urnov, Fyodor D.
    Rebar, Edward J.
    Holmes, Michael C.
    Zhang, H. Steve
    Gregory, Philip D.
    [J]. NATURE REVIEWS GENETICS, 2010, 11 (09) : 636 - 646
  • [94] Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
    Van Trung Chu
    Weber, Timm
    Wefers, Benedikt
    Wurst, Wolfgang
    Sander, Sandrine
    Rajewsky, Klaus
    Kuehn, Ralf
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (05) : 543 - U160
  • [95] Low Incidence of Off-Target Mutations in Individual CRISPR-Cas9 and TALEN Targeted Human Stem Cell Clones Detected by Whole-Genome Sequencing
    Veres, Adrian
    Gosis, Bridget S.
    Ding, Qiurong
    Collins, Ryan
    Ragavendran, Ashok
    Brand, Harrison
    Erdin, Serkan
    Cowan, Chad A.
    Talkowski, Michael E.
    Musunuru, Kiran
    [J]. CELL STEM CELL, 2014, 15 (01) : 27 - 30
  • [96] Engineering the Caenorhabditis elegans genome with CRISPR/Cas9
    Waaijers, Selma
    Boxem, Mike
    [J]. METHODS, 2014, 68 (03) : 381 - 388
  • [97] CRISPR/Cas9-Targeted Mutagenesis in Caenorhabditis elegans
    Waaijers, Selma
    Portegijs, Vincent
    Kerver, Jana
    Lemmens, Bennie B. L. G.
    Tijsterman, Marcel
    van den Heuvel, Sander
    Boxem, Mike
    [J]. GENETICS, 2013, 195 (03) : 1187 - +
  • [98] One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
    Wang, Haoyi
    Yang, Hui
    Shivalila, Chikdu S.
    Dawlaty, Meelad M.
    Cheng, Albert W.
    Zhang, Feng
    Jaenisch, Rudolf
    [J]. CELL, 2013, 153 (04) : 910 - 918
  • [99] Genetic Screens in Human Cells Using the CRISPR-Cas9 System
    Wang, Tim
    Wei, Jenny J.
    Sabatini, David M.
    Lander, Eric S.
    [J]. SCIENCE, 2014, 343 (6166) : 80 - 84
  • [100] Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
    Wang, Xiaoling
    Wang, Yebo
    Wu, Xiwei
    Wang, Jinhui
    Wang, Yingjia
    Qiu, Zhaojun
    Chang, Tammy
    Huang, He
    Lin, Ren-Jang
    Yee, Jiing-Kuan
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (02) : 175 - 178